Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone-Reference-Cited by-同舟云学术

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

Published:2008-08 Issue:7 Volume:154 Page:1465-1473
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Forrest M J,Bloomfield D,Briscoe R J,Brown P N,Cumiskey A-M,Ehrhart J,Hershey J C,Keller W J,Ma X,McPherson H E,Messina E,Peterson L B,Sharif-Rodriguez W,Siegl P K S,Sinclair P J,Sparrow C P,Stevenson A S,Sun S-Y,Tsai C,Vargas H,Walker M,West S H,White V,Woltmann R F

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/bjp.2008.229/fullpdf

Reference31 articles.

1. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience);Assmann;Am J Cardiol,1992

2. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis;Barter;Arterioscler Thromb Vasc Biol,2003

3. Effects of torcetrapib in patients at high risk for coronary events;Barter;N Engl J Med,2007

4. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol;Brousseau;N Engl J Med,2004

5. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib;Clark;Arterioscler Thromb Vasc Biol,2004

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

2. Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening;Frontiers in Toxicology;2024-03-25

3. Atherosclerotic plaque stabilization and regression: a review of clinical evidence;Nature Reviews Cardiology;2024-01-04

4. Current Assays in Endocrine Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

5. Evolving Therapeutic Targets;Clinical Lipidology;2024